Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls

被引:15
|
作者
Mazzoccoli, Gianluigi [1 ,2 ]
Sothern, Robert B. [3 ]
Parrella, Paola [4 ]
Muscarella, Lucia A. [4 ]
Fazio, Vito Michele [4 ]
Giuliani, Francesco [5 ]
Polyakova, Victoria [6 ,7 ]
Kvetnoy, Igor M. [6 ,7 ]
机构
[1] Sci Inst & Reg Gen Hosp Casa Sollievo Sofferenza, Dept Internal Med, Foggia, Italy
[2] Sci Inst & Reg Gen Hosp Casa Sollievo Sofferenza, Chronobiol Unit, Foggia, Italy
[3] Univ Minnesota, Rhythmometry Lab, St Paul, MN 55108 USA
[4] Sci Inst & Reg Gen Hosp Casa Sollievo Sofferenza, Res Lab Oncol, Foggia, Italy
[5] Sci Inst & Reg Gen Hosp Casa Sollievo Sofferenza, Comp Unit, Foggia, Italy
[6] Russian Acad Med Sci, Dept Pathol, Ott Inst Obstet & Gynecol, St Petersburg, Russia
[7] Inst Bioregulat & Gerontol, Dept Cell Biol & Pathol, St Petersburg, Russia
关键词
Lymphocyte subpopulations; NSCLC; Circadian rhythmicity; Cortisol; Melatonin; IL2; REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; PERIPHERAL-BLOOD; GENE-EXPRESSION; IMMUNE-SYSTEM; CLOCK; TIME; MELATONIN; RHYTHMS; SUBPOPULATIONS;
D O I
10.1007/s10238-011-0153-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lymphocyte subsets are major cellular components of the adaptive immune response and in most cases show 24-h (circadian) variations in health. In order to determine overall levels and circadian characteristics of cytotoxic natural killer (NK) and T and B lymphocyte subsets, blood samples were collected every 4 h for 24 h from eleven male controls (C) without neoplastic disease and nine men with untreated non-small cell lung cancer (NSCLC) and analyzed for 3 hormones (melatonin, cortisol, and interleukin 2 [IL2]) and for 11 lymphocyte subpopulations classified by cell surface clusters of differentiation (CD) and antigen receptors. Circadian rhythmicity for each variable was evaluated by ANOVA and 24 h cosine fitting and groups compared. Rhythms in melatonin and cortisol (peaks near 01:30 and 08:00 h) indicated identical synchronization to the light-dark schedule and probable persistent entrainment of rhythms for both groups in metabolism or proliferation of healthy tissues normally tightly coupled to the sleep-wake cycle. Twenty-four hours means were significantly higher in NSCLC for CD16, CD25, cortisol, and IL2 and lower for CD8, CD8bright, and gamma delta TCR. A significant circadian rhythm was found in C with daytime peaks for CD8, CD8dim, CD16, V delta 2TCR, and cortisol and nighttime peaks for CD3, CD4, CD20, and melatonin, and in NSCLC, with daytime peaks for CD16, gamma delta TCR, V delta 2TCR and cortisol, and nighttime peaks for CD4, CD25, and melatonin. Thus, NSCLC was associated with significant increases or decreases in proportions for several lymphocyte subsets that may reflect disease development, but peak times were nevertheless similar between C and NSCLC for each variable, suggesting that timed circadian administration (chronotherapy) of immunotherapy and other cancer treatments may improve efficacy due to persistent circadian entrainment of healthy tissues.
引用
收藏
页码:181 / 194
页数:14
相关论文
共 50 条
  • [41] CHARACTERISTICS AND OUTCOMES OF ADVANCED NON-SMALL CELL LUNG CANCER OF THE YOUNG PATIENTS
    Sakata, Hiroshi
    Kojima, Keisuke
    Sakata, Shinya
    Saeki, Sho
    Masunaga, Aiko
    Mizokami, Yuko
    Ideguchi, Hideharu
    Horio, Yuko
    Saruwatari, Kouichi
    Okamoto, Shinichiro
    Hirosako, Susumu
    Ichiyasu, Hidenori
    Fujii, Kazuhiko
    Kohrogi, Hirotsugu
    RESPIROLOGY, 2013, 18 : 83 - 83
  • [42] ASSESSING THE HEALTHCARE COST OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A428 - A428
  • [43] Lung Cancer Versus Young Cancer: Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?
    Bratova, Monika
    Brat, Kristian
    Hurdalkova, Karolina
    Barinova, Magda
    Drosslerova, Marie
    Kultan, Juraj
    Wanke, Matyas
    Koubkova, Leona
    Krejci, Jana
    Svaton, Martin
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2022, 11 (05) : 451 - 458
  • [44] Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.
    Karabou, Abdoulaye
    Bisseux, Laurence
    Pavese, Ida
    Collon, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Comparison of Exercise Capacity Respiratory Muscle Strength and Depression in Non-Small Cell Lung Cancer Patients and Healthy Controls
    Dundar, Zeynep Pelin
    Guclu, Meral Bosnak
    Ciltas, Aydin
    Benekli, Mustafa
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [46] Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
    Praveena Cheruvu
    Su K Metcalfe
    Justin Metcalfe
    Yuhchyau Chen
    Paul Okunieff
    Michael T Milano
    Radiation Oncology, 6
  • [47] Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer
    Kim, Hwan-Ik
    Noh, O. Kyu
    Oh, Young-Taek
    Chun, Mison
    Kim, Sang-Won
    Cho, Oyeon
    Heo, Jaesung
    RADIATION ONCOLOGY JOURNAL, 2016, 34 (03): : 202 - 208
  • [48] Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
    Cheruvu, Praveena
    Metcalfe, Su K.
    Metcalfe, Justin
    Chen, Yuhchyau
    Okunieff, Paul
    Milano, Michael T.
    RADIATION ONCOLOGY, 2011, 6
  • [49] PREOPERATIVE LYMPHOCYTE-TO-MONOCYTE RATIO VERSUS PLATELET-TO-LYMPHOCYTE RATIO AS A PROGNOSTIC PREDICTOR FOR NON-SMALL CELL LUNG CANCER PATIENTS
    Yan, Haixi
    Cai, Linling
    Chen, Shuaishuai
    Li, Jun
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (02) : 160 - 164
  • [50] Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study
    Wang, Yuyang
    Zhu, Jingjuan
    Zhou, Na
    Wang, Yun
    Zhang, Xiaochun
    JOURNAL OF THORACIC DISEASE, 2023, 15 (10) : 5669 - 5679